International Flavors & Fragrances (IFF)
Creates flavors, fragrances, enzymes, cultures, probiotics, and specialty bioscience ingredients for manufacturers.
$85.57
vs last close+1.97 (+2.36%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,820 | 2,703 | 2,899 | 2,889 | 2,925 | 2,771 | 2,843 | 2,764 | 2,694 | 2,589 | 2,741 | 1,954 |
| Cost of revenue | 1,896 | 1,843 | 1,875 | 1,821 | 1,873 | 1,791 | 1,808 | 1,734 | 1,711 | 1,699 | 1,723 | 1,101 |
| Gross profit | 924 | 860 | 1,024 | 1,068 | 1,052 | 980 | 1,035 | 1,030 | 983 | 890 | 1,018 | 853 |
| 774 | 3,396 | 825 | 877 | 803 | 853 | 1,938 | 832 | 757 | 777 | 739 | 695 | |
| Research & development | 157 | 157 | 166 | 173 | 162 | 170 | 164 | 182 | 174 | 174 | 166 | 170 |
| 444 | 444 | 490 | 493 | 495 | 517 | 461 | 483 | 421 | 469 | 427 | 437 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 421 | 0 | 0 | 0 |
| Other expenses | 173 | 2,795 | 169 | 211 | 146 | 166 | 1,313 | 167 | 162 | 134 | 146 | 88 |
| Operating income | 150 | −2,536 | 199 | 191 | 249 | 127 | −903 | 198 | 226 | 113 | 279 | 158 |
| −91 | −105 | −84 | −8 | −154 | −242 | −91 | 336 | −170 | −91 | −70 | −94 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 |
| Interest expense | 90 | 43 | 83 | 79 | 74 | 69 | 71 | 61 | 48 | 49 | 44 | 46 |
| Other non-operating income | 1 | 62 | 1 | −71 | 80 | 173 | 20 | −397 | 122 | 42 | 26 | 48 |
| Income before tax | 59 | −2,641 | 115 | 183 | 95 | −115 | −994 | 534 | 56 | 22 | 209 | 64 |
| Income tax expense | 32 | −32 | 54 | 11 | 35 | −69 | 23 | −78 | 15 | −9 | 39 | 31 |
| Net income from continuing operations | 27 | −2,609 | 61 | 172 | 60 | −46 | −1,017 | 612 | 41 | 31 | 170 | 33 |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18 |
| Net income | 25 | −2,607 | 60 | 170 | 59 | −46 | −1,018 | 612 | 40 | 31 | 169 | 50 |
| EPS, basic | $0.10 | −$10.24 | $0.24 | $0.67 | $0.23 | −$0.18 | −$3.98 | $2.39 | $0.16 | $0.07 | $0.66 | $0.20 |
| EPS, diluted | $0.10 | −$10.24 | $0.23 | $0.66 | $0.23 | −$0.18 | −$3.98 | $2.38 | $0.16 | $0.07 | $0.66 | $0.19 |
| Weighted average shares, basic | 255 | 255 | 255 | 255 | 256 | 256 | 256 | 256 | 256 | 256 | 256 | 256 |
| Weighted average shares, diluted | 256 | 255 | 256 | 256 | 257 | 256 | 256 | 257 | 257 | 257 | 257 | 257 |
| EBITDA | 441 | −2,311 | 476 | 508 | 417 | 197 | −687 | 837 | 351 | 308 | 499 | 328 |
| Depreciation & amortization | 292 | 287 | 278 | 246 | 248 | 243 | 236 | 242 | 247 | 237 | 246 | 218 |
| EBIT | 149 | −2,598 | 198 | 262 | 169 | −46 | −923 | 595 | 104 | 71 | 253 | 110 |
